EUVIMEDEUVIMED entdecken
Crossref

Vicinal dithiol proteins-triggered prodrug activation: A novel strategy for Cancer-specific imaging and therapy

Suntao Shi, Ruipeng Shen, Yating Chen, Mengzhao Zhang, Jingyi Liu, Chunlin Sun, Haijuan Zhang, Baoxin Zhang

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.109552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Suntao Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Product Chemistry and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Breast Neoplasms. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Science and Technology Program of Gansu Province, Gansu Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Theranostic platforms have garnered considerable attention as a promising strategy to enhance the precision and efficacy of cancer treatment. Vicinal dithiol proteins (VDPs) are critical for maintaining cellular redox balance, and their dysregulation is associated with various pathological conditions, such as cancer, stroke and neurodegenerative diseases. Herein, we design a novel VDPs-activated theranostic prodrug, Lena-green, which incorporates an α, β-unsaturated acrylamide group as a recognition site for the first time. Upon exposure to VDPs, Lena-green conjugates the fluorophore to VDPs while releasing lenalidomide (Lena), a clinically established anticancer drug, enabling fluorescence-based tracking and achieving high drug release efficiency in vitro. In murine models of subcutaneous breast cancer, Lena-green exhibited significantly enhanced therapeutic efficacy. This innovative design provides a promising strategy for real-time monitoring of drug release, thereby improving the precision and effectiveness of cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsBreast NeoplasmsAnimalsHumansMiceFemaleCell ProliferationMolecular StructureDrug Screening Assays, AntitumorOptical ImagingMammary Neoplasms, ExperimentalDose-Response Relationship, DrugStructure-Activity RelationshipDrug LiberationToluene

Stichwörter der Autor:innen

Theranostic prodrugVicinal dithiol proteinsα, β-unsaturated acrylamide

Substanzen

ProdrugsAntineoplastic AgentsdithiolToluene

Autor:innen und Institutionen

  • State Key Laboratory of Natural Product Chemistry and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
  • State Key Laboratory of Natural Product Chemistry and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Electronic address: zhangbx@lzu.edu.cn.

Förderung

  • Science and Technology Program of Gansu Province
  • Gansu Provincial Natural Science Foundation

Zitieren

APA

Shi, S., Shen, R., Chen, Y., Zhang, M., Liu, J., Sun, C., Zhang, H., & Zhang, B. (2026). Vicinal dithiol proteins-triggered prodrug activation: A novel strategy for Cancer-specific imaging and therapy. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109552

Vancouver

Shi S, Shen R, Chen Y, Zhang M, Liu J, Sun C, et al. Vicinal dithiol proteins-triggered prodrug activation: A novel strategy for Cancer-specific imaging and therapy. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109552

BibTeX
@article{Shi2026,
  author = {Shi, Suntao and Shen, Ruipeng and Chen, Yating and Zhang, Mengzhao and Liu, Jingyi and Sun, Chunlin and Zhang, Haijuan and Zhang, Baoxin},
  title = {Vicinal dithiol proteins-triggered prodrug activation: A novel strategy for Cancer-specific imaging and therapy},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.109552}
}
Kostenlos starten →